JOINT FILING AGREEMENT
Exhibit 99.1
The undersigned agree that the attached Schedule 13G dated February 3, 2021 relating to the Common Stock, par value $0.0001 per share, of Syndax Therapeutics, Inc. shall be filed on behalf of the undersigned.
Dated: February 3, 2021
AI LIFE SCIENCES INVESTMENTS LLC
By: AI LSI Management, LLC, Its Managing Member | ||||||||
By: | Access Industries Management, LLC | |||||||
Its Manager | ||||||||
/s/ Xxxxxxxxx Xxxxxx | ||||||||
Signature | ||||||||
Xxxxxxxxx Xxxxxx / Executive Vice President | ||||||||
Name/Title | ||||||||
ACCESS INDUSTRIES HOLDINGS LLC | ||||||||
By: Access Industries Management, LLC, Its Manager | ||||||||
/s/ Xxxxxxxxx Xxxxxx | ||||||||
Signature | ||||||||
Xxxxxxxxx Xxxxxx / Executive Vice President | ||||||||
Name/Title | ||||||||
ACCESS INDUSTRIES MANAGEMENT, LLC | ||||||||
By: | ||||||||
/s/ Xxxxxxxxx Xxxxxx | ||||||||
Signature | ||||||||
Xxxxxxxxx Xxxxxx / Executive Vice President | ||||||||
Name/Title | ||||||||
* | ||||||||
Signature | ||||||||
Xxx Xxxxxxxxx | ||||||||
Name |
* | The undersigned, by signing his name hereto, executes this Joint Filing Agreement on behalf of Xx. Xxxxxxxxx pursuant to the Limited Power of Attorney filed with the Securities and Exchange Commission on July 24, 2020. |
By: | /s/ Xxxxxxxxx Xxxxxx | |
Name: | Xxxxxxxxx Xxxxxx | |
Attorney-in-Fact |